Hearing loss affects more than 1.5 billion people worldwide. While aging is a common cause, infections during childhood and adolescence also play a major role. Many of these infections can be prevented through vaccination, especially in low- and middle-income countries where hearing care is limited.
Researchers from Université de Montréal’s School of Public Health conducted a detailed review of scientific studies on how vaccines might protect children from hearing loss. Their work, published in Communications Medicine, highlights the potential of vaccines to reduce hearing problems caused by infections like rubella, meningitis, and mumps.
The team examined 26 infectious agents linked to hearing loss and identified the vaccines available against them. They found only nine studies over the last 40 years that looked at vaccine effects on hearing loss. These studies were conducted mostly in wealthy countries, showing a clear lack of data from low-income areas.
Vaccination programs against rubella and mumps have led to fewer cases of deafness in countries like Australia and Sweden. However, research on pneumococcal vaccines did not show a strong effect on reducing ear infections that can cause hearing loss. The variation in study methods makes it hard to compare results directly.
Raising awareness about how vaccines can prevent hearing loss may strengthen vaccination efforts globally. Including hearing loss prevention in vaccine evaluations could also guide better research and policy decisions. Improving vaccine access, especially in poorer countries, is vital to reducing avoidable hearing disabilities.
This study points out that vaccines do more than save lives—they protect hearing and improve children’s quality of life. Canada’s success in lowering childhood hearing loss through vaccines and antibiotics offers a hopeful example that can be followed worldwide.
